Edward R. Conner's Net Worth
$2.73 Million
Who is Edward R. Conner?
Edward R. Conner has an estimated net worth of $2.73 Million. This is based on reported shares across multiple companies, which include SANGAMO THERAPEUTICS, INC, IMARA Inc., Audentes Therapeutics, Inc., and Third Harmonic Bio, Inc..
SEC CIK
Edward R. Conner's CIK is 0001691265
Past Insider Trading and Trends
2018 was Edward R. Conner's most active year for acquiring shares with 14 total transactions. Edward R. Conner's most active month to acquire stocks was the month of December. 2018 was Edward R. Conner's most active year for disposing of shares, totalling 24 transactions. Edward R. Conner's most active month to dispose stocks was the month of December. 2023 saw Edward R. Conner paying a total of $20,118.00 for 624,868 shares, this is the most they've acquired in one year. In 2020 Edward R. Conner cashed out on 114,584 shares for a total of $1,475,040.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SANGAMO THERAPEUTICS, INC (SGMO) Snapshot price: $0.4902
Sr. VP & Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.88% | -834.00 |
$11.10 | -$9,257.40 | 11.29K |
Jan 24
| |||
Form 4
|
—
|
0
|
$7.77 | -$45,630.50 | 12.13K |
Scheduled
|
Jan 7
| ||
Form 4
|
—
|
0
|
$7.35 | -$41,433.00 | 12.13K |
Scheduled
|
Dec 6
| ||
Form 4
|
—
|
0
|
$8.47 | -$52,650.00 | 12.13K |
Scheduled
|
Nov 6
| ||
Form 4
|
—
|
0
|
$8.88 | -$56,773.50 | 10.13K |
Scheduled
|
Oct 8
| ||
Form 4
|
—
|
0
|
$8.69 | -$54,845.00 | 10.13K |
Scheduled
|
Sep 6
| ||
Form 4
|
—
|
0
|
$8.32 | -$51,250.00 | 10.13K |
Scheduled
|
Aug 6
| ||
Form 4
|
—
|
0
|
$9.50 | -$62,975.00 | 10.13K |
Scheduled
|
Jul 6
| ||
Form 4
|
—
|
0
|
$9.94 | -$67,350.00 | 10.13K |
Scheduled
|
Jun 6
| ||
Form 4
|
—
|
0
|
$9.78 | -$65,814.00 | 10.13K |
Scheduled
|
May 7
| ||
Form 4
|
—
|
0
|
$10.31 | -$71,065.00 | 8.13K |
Scheduled
|
Apr 6
| ||
Form 4
|
—
|
0
|
$13.99 | -$107,877.50 | 8.13K |
Scheduled
|
Mar 6
| ||
Form 4
|
—
|
0
|
$10.85 | -$76,435.50 | 8.13K |
Scheduled
|
Feb 6
| ||
Form 4
| +306.25% | 6.13K |
—
|
—
| 8.13K |
Jan 24
| |||
Form 4
|
—
|
0
|
$10.15 | -$69,545.00 | 2K |
Scheduled
|
Jan 8
| ||
Form 4
|
—
|
0
|
$9.72 | -$65,200.00 |
0
|
Scheduled
|
Dec 6
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
IMARA Inc. (ELVN) Snapshot price: $15.53
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Audentes Therapeutics, Inc. No price found
SVP, Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -24.58K |
$60.00 | -$1,475,040.00 |
0
|
Jan 15
| |||
Form 4
| -18.05% | -5.42K |
$59.37 | -$321,547.92 | 24.58K |
Dec 12
| |||
Form 4
|
∞
| 30K |
—
|
—
| 30K |
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Third Harmonic Bio, Inc. (THRD) Snapshot price: $8.87
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
|
—
|
0
|
$7.12 | -$27,944.38 |
0
|
Scheduled
|
Dec 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |